CureVac (CVAC) Income Statement: Revenue & Earnings

CureVac Income Statement Analysis

Revenue, earnings, and profit margins in millions EUR

Scale:

Scroll to see more

CureVac N.V. income statement - Annual data in millions EUR
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	535.18	53.76	67.42	102.99	48.87
Cost of Revenue	105.83	116.21	183.99	238.20	14.17
Gross Profit	429.35	-62.45	-116.57	-135.21	34.70
Operating Expenses
Research & Development	153.03	115.72	62.55	815.91	113.81
Selling, General & Administrative	60.82	95.74	89.78	88.86	54.29
Operating Expenses	251.67	203.67	132.88	277.06	168.25
Operating Income	177.68	-266.12	-249.46	-412.26	-133.55
Other Income/Expense
Interest Income	12.36	2.02	1.73	10.10	2.07
Interest Expense	0.00	0.00	2.30	10.34	-22.10
Other Income/Expense	0.84	13.43	0.87	0.32	0.00
Income
Income Before Tax	190.88	-259.97	-249.16	-412.50	-129.85
Income Tax Expense	28.70	0.20	-0.13	-0.78	-0.73
Net Income	162.19	-260.17	-249.03	-411.72	-129.12
Net Income - Continuous Operations	162.19	-260.17	-249.03	-411.72	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	209.69	-249.33	-223.12	-386.49	-123.10
EBIT	190.88	-266.12	-246.86	-402.16	-133.55
Depreciation & Amortization	7.81	16.79	11.36	8.98	10.46
Earnings Per Share
Basic EPS	1.00	-1.00	-1.00	-2.00	-1.00
Diluted EPS	1.00	-1.00	-1.00	-2.00	-1.00
Basic Shares Outstanding	224.38	220.91	189.07	186.01	132.20
Diluted Shares Outstanding	225.27	220.91	189.07	186.01	132.20